SCHEMBL25680640

SCHEMBL25680640

Cc1cccc(NC(=O)c2ccc(O)c(C)c2C)c1C

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.70
RAB9A P51151 7/20 0.70
HSD17B10 Q99714 4/20 0.70
LMNA P02545 3/20 0.70
HTT P42858 2/20 0.70
TP53 P04637 1/20 0.70
TSHR P16473 1/20 0.70
CRHBP P24387 1/20 0.56
CRHR2 Q13324 1/20 0.56
KDM4E B2RXH2 3/20 0.54
ALDH1A1 P00352 3/20 0.54
HPGD P15428 3/20 0.54
MAPK1 P28482 1/20 0.54
SMN1; SMN2 Q16637 4/20 0.53
ATM Q13315 1/20 0.52
RXFP1 Q9HBX9 2/20 0.51
MAPT P10636 4/20 0.50
MAOB P27338 2/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30186404 0.84 NPC1 (0.69) NPC1RAB9AHSD17B10LMNAHTT
SCHEMBL25680644 0.84 NPC1 (0.69) NPC1RAB9AHSD17B10LMNAHTT
SCHEMBL20511410 0.81 KDM4E (0.68) NPC1RAB9AHSD17B10LMNAHTT
SCHEMBL24460183 0.80 LMNA (0.68) NPC1RAB9AHSD17B10LMNAHTT
SCHEMBL30771734 0.80 LMNA (0.68) NPC1RAB9AHSD17B10LMNAHTT
SCHEMBL7189667 0.79 NPC1 (0.71) NPC1RAB9AHSD17B10LMNAHTT
SCHEMBL11766410 0.77 NPC1 (0.64) NPC1RAB9AHSD17B10LMNAHTT
SCHEMBL28652342 0.77 HSD17B10 (0.70) NPC1RAB9AHSD17B10LMNAHTT
SCHEMBL20511433 0.77 NPC1 (0.59) NPC1RAB9AHSD17B10LMNAHTT
SCHEMBL29438754 0.76 NPC1 (0.72) NPC1RAB9AHSD17B10LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230142508-A1 COMPOUNDS AND METHODS FOR REGULATING INSULIN SECRETION THE BROAD INSTITUTE, INC. (US) 2023-05-11 US disclosed
US-20230142508-A1 COMPOUNDS AND METHODS FOR REGULATING INSULIN SECRETION THE BROAD INSTITUTE, INC. (US) 2023-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230142508-A1 COMPOUNDS AND METHODS FOR REGULATING INSULIN SECRETION IAPP, GPR119, PNLIP NPC1 728/4885RAB9A 2004/4885HSD17B10 1317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.